Channels Chemotherapeutic drugs, 5-fluorouracil and cisplatin, differentially affect exprssion of drug metabolising enzyme genes in an oesophageal cancer cell line
Interaction between host genetics and drug therapy in influencing gut bacterial diversity
The role of genetic variation in VKORC1 and GGCX on warfarin response in a South African population
Type 2 diabetes mellitus and dyslipidaemia: effects of genetic variation in African populations
Pharmacogenetics of resistant hypertension: evaluating the role of genetic variation in ABCB1, ADBR1, CES1, CYP3A4, CYP3A5, NEDD4L, NOS3, NR3C2 and SCNN1B among South African hypertensive patient
The pharmacologenetics of lopinavir in a cohort of black African HIV/AIDS patients
Human host and malaria parasite genome variations to susceptibility to malaria
Pharmacogenomics of warfarin: comprehensive evaluation of important warfarin genomic response factors
Chemotherapeutic drugs, 5-fluorouracil and cisplatin, differentially affect exprssion of drug metabolising enzyme genes in an oesophageal cancer cell line
Virus restriction gene variants and their possible role in neurocognitive function in children born to HIV-infected mothers
Determining the role of differential expression of candidate icroRNAs in cardiometabolic diseases among South African adults living with HIV
Role of antiretroviral therapy exposure host genetics on cytomegalovirus infection status and association with gut microbiome profiles among pregnant black African women
Associations of genetic variants in ABCB1, ABCG2, CYP3A4, CYP3A5, and SLCO1B1 with statin-associated muscle symptom (SAMS) in South African populations
Pharmacogenetics of stavundine : role of genetic variation in mitochondrial DNA and polymerase gamma among adult Malawian HIV/AIDS patients
Pharmacogenetics of Efavirenz response in Bantu-speaking South African HIV/AIDS patients
APOE, PCSK9, and CETP genetic variants as potential biomarkers of dyslipidaemia in black South Africans with Type 2 Diabetes Mellitus
